INTRODUCTION
The fragile X syndrome is one of the most common genetic disorders with an incidence of 1 in 1,500 males (Sutherland and Hecht, 1985) . This syndrome segregates dominantly in X-linked manner with reduced penetrance since both sex carrying this mutation may exhibit mental retardation. The syndrome has been shown to associate with a cytogenetic marker, a folate-sensitive fragile site located at Xq27.3, which is expressed under the conditions of thymidylate stress (Sutherland and Hecht, 1985; Hori et al., 1988) . Identification of the cytogenetic carrier, however, was usually difficult for the following complications of the syndrome: (1) Majority of males carrying the fragile X mutation exhibits both clinical manifestations and cytogenetic expression of fra(X)(q27.3), but 20 ~ of males with mutation do not express the fragile site and are phenotypically normal (so-called normal transmitting males). ]'he normal transmitting males transmit the mutation to their daughters and have fully affected grandsons. (2) While two thirds of female heterozygotes are phenotypically unaffected and also FRAXA expression is not observed, remaining one third of female carriers are intellectually impaired with FRAXA expression.
Recently the nature of the fragile X mutation has been uncovered at molecular level. Kremer et al. (199t) reported that the characteristic trinucleotide repeat, (CCG)=, was found in the restriction fragment where break point of the fragile site may lay. The size of the restriction fragments were increased in DNA samples derived from the fragile X patients when subjected to Southern blot analysis. This suggested amplification of the (CCG)= repeat in the fragile X patients may be responsible both in the increase of the restriction fragment and in the fragility of this particular locus.
Polymerase chain reaction (PCR) is one of the most convenient procedure to prepare DNA probes for screening and/or diagnosis as well as for direct detection of mutations in target genes, but specific amplification of the fragile X locus across (CCG)~ repeat has not been successful (our unpublished observation).
In the present study we tried to prepare diagnostic DNA probes by direct enzymatic amplification of the human chromosomal DNA, and established the reproducible condition for direct PCR of both flanking region of the (CCG)n repeat in the fragile X locus. The PCR products were further used to screen the partiallydigested human genomic DNA library, and two overlapping clones were isolated and shown to be originated from Xq27.3 by in situ hybridization. We also describe here that the Southern blot analysis of the DNA samples probed by PCR products (PstI-assay) can detect restriction fragment length variations between normal, heterozygous carrier, and patient affected by the fragile X syndrome.
MATERIALS AND METHODS

Polymerase chain reaction (PCR).
We used two sets of oligonucleotide primers to amplify each adjacent part to the (CCG)~ repeat as shown in Fig. 1 . The nucleotide sequences of the primers were as follows : FX-F1 : 5'-CTGCAGAAATGGGCGTTCTGGC-3' FX-F2: 5'-GTGTCACCGCCCTTCAGCCTTC-3' FX-F3 : 5'-CACCTCTCGGGGGCGGGCTCCC-3' FX-F4: 5'-CGCTAGCAGGGCTGAAGAGAAG-3' FX-R1 : 5'-CTGCAGGAGGTGGCCCGGCTGA-3' FX-R2: 5'-CAACTACCCACACGACAGGCCC-3' FX-R3 : 5'-CGGAAGTGAAACGAAACGGAGC-3' FX-R4: 5'-CGGCCCGCCGCCCGCTCAGAGA-3' The chromosomal DNA samples were extracted by the standard procedure. PCR was performed in a reaction mixture (50 tA) containing 67 mM Tris-HC1 (pH 8.8), 17 mM ammonium sulfate, 2 mM magnesium chloride, 0.45~ Triton X-100, 0.2 mg/ml gelatin, 1 t~g of chromosomal DNA, and 6 ng each of appropriate oligo primers as recommended by the manufacturer (Biotech International Ltd., Australia). PCR was performed reciprocally between 95~ and 72~ for 1 rain each, by 30 cycles without typical annealing step. For colony PCR each small portion of colonies of transformants was directly put into reaction mixture, and the reactions were carried out using universal primers, M4 and RV (Takara, Ohtsu, Japan) by the standard condition (93~ 1 min~60~ 1 min-.72~ 1 rain, 30 cycles). All polymerase chain reactions were carried out in the DNA Thermal Cycler (Perkin Elmer Cetus, USA).
Analysis of the PCR products. The secondary PCR products were digested by appropriate restriction endonueleases ( Fig. I ) and were subcloned into pUC119 plasmid vector. White colonies were selected on X-gal plates containing ampicillin, and the sizes of inserts were examined by colony PCR technique as described above.
DNA samples of fragile X patients. Total genomic DNA was extracted from human lymphoblastoid cell lines and somatic cell hybrids. The lymphoblastoid cell lines established from male patients with the fragile X syndrome (FX132, 135, 137, and 310) were provided by I. Kondo (Ehime Univ.). The FX312 was from an affected female heterozygote who expressed fra(X)(q27.3) and FX311 was from normal male in the same family of FX310 (Arinami et al., 1987) . A cell line FX-86-111, from a fragile X male patient was provided by T. Kajii (Yamaguehi Univ.). Somatic hybrid cell lines retaining a human fragile X chromosome were established by cell fusions between mouse cells and skin fibroblasts of fragile X male patients: TS/86, FSthy21 and 86-111; 13H5, tsFT20 and RS4729 (Hori et al., 1988) . The other cell lines for controls were developed by K. Yamamoto and T. Ikeuchi (Tokyo Med. Dent. Univ.), and by T. Hashimoto (Hyogo Med. Univ.) by EBV-transformation of peripheral blood lymphocytes from carriers of autosomal rare fragile sites (D3, B3, HeD5, L-177-1, L-118, L-118-1, and L-118-2), and from patients affected by ataxia telangiectasia (ATMO, ATFU, and AT53), respectively. The HeD5, L-118, ATMO, and AT53 were derived from females and all the others were from males.
Southern blot hybridization. Restriction digests of DNA samples were subjected to 1 ~ agarose gel electrophoresis, and were alkali-transferred to a nylon membrane filter (Zetaprobe, BioRad, USA). Hybridization was performed by the standard condition in 3 x SSC-50~ formamide containing salmon sperm DNA, Denhaldt's solution and dextran sulfate at 42~ overnight. Filters were washed in 0.1 x SSC-0.1 ~ SDS at 60~ twice, and then autoradiographed.
RESULTS AND DISCUSSION
Polymerase chain reaction
For direct and specific amplification of DNA fragments from the fragile X Vol. 37, No. 3, 1992 region using human chromosomal DNA as a template, we set oligonucleotide primers as described in the MATERIALS AND METHODS and Fig. i . In our preliminary experiments the standard condition (i.e. 93~ 1 min--60~ 1 min--72~ 1 min, 30 cycles) was employed for PCR step cycle, and those experiments resulted in having very high backgrounds even when nested oligos were used in the secondary PCR, perhaps because of unusually high GC content around the region. Then we started to manipulate the reaction condition, changing the concentrations of salts, of dNTPs and of magnesium as well as temperatures in the step cycle. We also examined several sources of Taq DNA polymerases from different manufacturers. We finally found out that the combination with the reaction composition and Taq DNA polymerase from Biotech using reciprocal cycle for PCR as described in MATERIALS AND METHODS has given the most consistent results both in yield and in specificity of the amplification.
Although little specific PCR products were amplified after primary amplification using various combinations of oligo-primers (lanes 1-6 in Fig. 2) , it appeared to have specific products after secondary PCR using nested-oligos. Especially when PCR was performed using the primer combination, F3 + R1, and then using F4+R2, the specific DNA fragment of 0.5 kb was observed most reproducibly (lane 10). Using F2+R4 as nested-oligos after the first PCR using FI +R3 also gave successful results, but the specificity of the resultant product was a little lower than using F3+R1--,F4+R2 (lane 9). It is noteworthy that specific products can be seen on the lanes 7 and 8 after the second PCR, suggesting enzymatic amplification has occurred across the (CCG)n repeat using oligo-primers, F1 + R1, though the yields of PCR products had been significantly lower. DNA fragments which seemed to be the same sizes as specific products were sometimes observed after primary amplification using F2+ R4 and F4+ R2, but the results were not always successful after multiple repeats of the same experiments. Digestion of chromosomal DNA by Pstl prior to PCR did not make any differences both in yield and in specificity of the amplification. A!ignment of oIigo-nucleotide primers and restriction sites around the (CCG)n repeat. Each adjacent part to the trinucleotide repeat was primarily amplified using either FI+R3 or F3 § Primary PCR products were then amplified again using nested-oligos, F2+R4 and F4 § respectively. Resultant PCR products were subcloned into pUCll9 plasmid vector at appropriate restriction sites for further analyses. Fig. 2 . Ethidium bromide staining of the PCR products. PCR products were subjected to 1 ~ agarose gel electrophoresis and were stained by ethidium bromide. Product sizes here are slightly larger than those represented in Fig. t because the products were not digested by restriction endonucleases yet. Primer combinations employed for each lane was as follows:
Isolation of genomic DNA clones PCR products were then subjected to appropriate restriction digestions and D N A fragments were subcloned into p C U l l 9 plasmid vector. Genomic clones were screened from the partially-digested human genomic D N A libraries as described previously (Yamauchi et aI., 1990 (Yamauchi et aI., , 1991 for the PCR products were not long enough for in situ hybridization. Several clones were identified and two of them appeared to cover up to 20 kb around the (CCG)~ repeat as shown in Fig. 3 . Our restriction map of the clones coincided to the ones which have been constructed on the D N A fragments derived from yeast artificial chromosome (YAC) clones spanning the fragile X breakpoint (Verkerk et al., 1991; Yu et aI., 1991; Kremer et al., 1991) . The chromosomal location of the genomic clones isolated here were further confirmed by fluorescence in situ hybridization to localize at the expressed site of the fragile X chromosome (data not shown). This suggests that the PCR products amplified and subcloned here were highly specific and could be used as diagnostic probes for the fragile X syndrome. ;tNlll
AIIII
Human partially-digested genomic DNA clones covering the fragile X region. Solid box represents the (CCG)n repeat. PCR products which were derived from the PstI fragment containing (CCG)n repeat were used as probes. Several clones were identified from the library and two of them (bottom solid lines) appeared to overlap, covering about 20 kb around the (CCG)~ repeat. The two genomic clones were further confirmed to derive from the fragile site by in situ hybridization technique.
Southern blot analysis
To examine if the PCR products subcloned here could be applicable for diagnostic purpose using Southern blot hybridization technique, we employed DNA samples from various sources including the fragile X syndrome male patients, a female carrier, somatic cell hybrids between skin fibroblasts from fragile X male patients and cultured mouse cell lines, and normal individuals. Typical results of Southern blot analysis on EcoRI-digested and PstI-digested DNA samples are shown in Fig. 4a and 4b , respectively. A 5 kb-EcoRI fragment and a 1 kb-PstI fragment were detected from both normal controls and an affected female (FX312) using radio-labeled 0.5 kb PCR product. FX311 was a fragile X-negative male, and showed normal size of the restriction fragment. These results were consistent with the ones reported by other groups (Verkerk et al., 1991 ; Yu et al., 1991 ; Kremer et aL, 1991) , and any size variations in the restriction fragments were not observed among normal DNA samples in our assay conditions.
In contrast, significant alterations were observed in the mobilities of restriction fragments from both the fragile X patients and the hybrid cells (Fig. 4) . In case of the EcoRI-digested samples the size of restriction fragments were increased up to 8 kb (Fig. 4a) . These size variations can be detected more clearly in the PstI-digested samples, where the sizes were varying from 1.5 kb to 4.0 kb comparing to the normal size of 1.0 kb (Fig. 4b) . The differences in the size of restriction fragments (0.5-3.0 kb) were consistent between the EcoRI-digested samples and the PstI-digested ones. This suggests that the size variation should be due to the changes occurred within 1 kb-PstI fragments.
To explain the molecular basis of these size variations, the simplest explanation would be increased copy number of the (CCG)~ repeat. Kremer et al. (1991) reported when they have analyzed the copy number of the (CCG)~ repeat in a hybrid cells derived from a fragile X-expressing male, the repeat length have fallen within the normal range of 43 copies in a genomic DNA clone isolated from the hybrid cells while the size of restriction fragment containing the (CCG)~ repeat have sig-nificantly aitered in the original affected male patient. This suggests the DNA fragment containing the (CCG)n repeat is unstable during cloning process. Another characteristic aspect of the altered restriction fragments detected in the fragile X patients was that some of them have shown length variation of these fragments. This suggests that a chromosomal region containing (CCG)~ repeat seemed not to be maintained stably even in a single individual. The somatic variations observed in the affected patients might be the consequence of unequal sister chromatid exchange after DNA replication of the mutated X chromosome. In addition we observed in our preliminary experiments on fragile X families that the size of PstI-fragments were increased when the mutant chromosomes were transmitted by females, but not were increased when transmitted by males as previously reported by Yu et aL (1991) .
In conclusion, the DNA probes described here, which were directly amplified from chromosomal DNA, can be applicable for diagnostic purpose to detect the length variations in the fragile X-expressing individuals. But we need further experiments for carrier detection and prenatal diagnosis for the fragile X syndrome since some fragile X-positive individuals without exhibition of any detectable length variation have been reported (Nakahori et aL, 1991) . In our another preliminary experiment we have been accumulating consistent observations in detecting the transcript of FMR gene, which is expressed from fragile X region, using RT-PCR technique . The combination of Southern blot analysis and RT-PCR would raise the accuracy of diagnostic detection of the fragile X syndrome to satisfactory level. The definitive diagnosis of the fragile X syndrome by molecular basis will soon replace the cytogenetic one.
